tldrdailynews.com logo

Moderna Halts CMV and Birth Defects Vaccine Programs After Trial Failures

1 min read
Source: statnews.com
Moderna Halts CMV and Birth Defects Vaccine Programs After Trial Failures
Photo: statnews.com
TL;DR

Moderna's experimental cytomegalovirus (CMV) vaccine failed in a Phase 3 trial, marking a significant setback for the company, which had high sales expectations for the vaccine prior to the failure amid ongoing pressures from Wall Street and the government.

Topics:businesshealthcare#biotech#cmv-vaccine#healthcare#moderna#phase-3-trial#setback
Share this article
  1. Moderna says key study of its CMV vaccine, expected to be its next big win, failed  statnews.com
  2. Moderna scraps congenital virus program after vaccine shows little protective effect in phase 3  Fierce Biotech
  3. Moderna halts development of birth defect vaccine after trial setback  Reuters
  4. Moderna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint  Yahoo Finance
  5. Moderna Drops Vaccine for Birth Defects After Trial Failure  Barron's

Want the full story? Read the original reporting

Read on statnews.com